ROYAL BANK OF CANADA - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,000
+50.0%
6,452
+99.0%
0.00%
Q2 2023$4,000
-85.2%
3,242
-85.1%
0.00%
Q1 2023$27,00021,759
+144960.0%
0.00%
Q4 2022$0
-100.0%
15
-99.2%
0.00%
Q2 2021$4,000
-60.0%
1,980
-48.5%
0.00%
Q1 2021$10,000
+66.7%
3,846
+32.3%
0.00%
Q4 2020$6,0002,908
+96833.3%
0.00%
Q3 2020$0
-100.0%
3
-99.5%
0.00%
Q2 2020$2,000
+100.0%
614
+29.5%
0.00%
Q3 2019$1,000474
+1002.3%
0.00%
Q3 2018$0
-100.0%
43
-91.5%
0.00%
Q1 2017$4,000
-50.0%
504
-33.5%
0.00%
Q4 2016$8,000
+100.0%
758
+157.8%
0.00%
Q3 2015$4,000
-20.0%
294
-10.6%
0.00%
Q2 2015$5,0003290.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,356,813$3,189,0004.48%
Omega Fund Management, LLC 1,508,794$3,546,0002.63%
ALETHEA CAPITAL MANAGEMENT, LLC 482,357$1,134,0001.65%
Opaleye Management Inc. 1,200,000$2,820,0001.05%
BVF INC/IL 2,904,684$6,826,0000.89%
FRAZIER MANAGEMENT LLC 1,312,258$3,084,0000.80%
Monashee Investment Management LLC 480,851$1,130,0000.76%
Aisling Capital LLC 1,021,148$2,400,0000.68%
Trellus Management Company, LLC 94,143$221,0000.50%
Prosight Management, LP 245,764$578,0000.30%
View complete list of CIDARA THERAPEUTICS INC shareholders